Regulation of receptor tyrosine kinase ligand processing

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 1, 2014, Pages

  Adrain, Colin ^a,b   Freeman, Matthew ^a,c  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; PROTEIN TYROSINE KINASE;

ANIMAL; ARTICLE; DROSOPHILA; MAMMAL; METABOLISM; PROTEIN DEGRADATION;

ANIMALS; DROSOPHILA; LIGANDS; MAMMALS; PROTEOLYSIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84891646642     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a008995     Document Type: Article

References (136)

1. Adrain C, Freeman M. 2012. New lives for old: Evolution of pseudoenzyme function illustrated by iRhoms. Nat Rev Mol Cell Biol 13: 489-498.
2. Adrain C, Strisovsky K, Zettl M, Hu L, Lemberg MK, Freeman M. 2011. Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep 12: 421-427.
3. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M. 2012. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335: 225-228.
4. Arduise C, Abache T, Li L, Billard M, Chabanon A, Ludwig A, Mauduit P, Boucheix C, Rubinstein E, Le Naour F. 2008. Tetraspanins regulate ADAM10-mediated cleavage of TNF-a and epidermal growth factor. J Immunol 181: 7002-7013.
5. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, et al. 2002. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy. Nat Med 8: 35-40.
6. Ashman LK. 1999. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 31: 1037-1051.
7. Baselga J, Mendelsohn J, Kim YM, Pandiella A. 1996. Autocrine regulation of membrane transforming growth factor-a cleavage. J Biol Chem 271: 3279-3284.
8. Berditchevski F, Odintsova E. 2007. Tetraspanins as regulators of protein trafficking. Traffic 8: 89-96.
9. Bier E, Jan LY, Jan YN. 1990. Rhomboid, a gene required for dorsoventral axis establishment and peripheral nervous system development in Drosophila melanogaster. Genes Dev 4: 190-203.
10. Black RA, RauchCT, Kozlosky CJ, Peschon JJ, Slack JL, WolfsonMF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-a from cells. Nature 385: 729-733.
11. Blobel CP. 2005. ADAMs: Key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6: 32-43.
12. Blobel CP, White JM. 1992. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol 4: 760-765.
13. Brannan CI, Lyman SD, Williams DE, Eisenman J, Anderson DM, Cosman D, Bedell MA, Jenkins NA, Copeland NG. 1991. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci 88: 4671-4674.
14. Brown KE, Kerr M, Freeman M. 2007. The EGFR ligands Spitz and Keren act cooperatively in the Drosophila eye. Dev Biol 307: 105-113.
15. Cecchini MG, HofstetterW, Halasy J, Wetterwald A, Felix R. 1997. Role of CSF-1 in bone and bone marrow development. Mol Reprod Dev 46: 75-83; discussion 83-4.
16. Citri A, Skaria KB, Yarden Y. 2003. The deaf and the dumb: The biology of ErbB-2 and ErbB-3. Exp Cell Res 284: 54-65.
17. Cook PW, Mattox PA, KeebleWW, Pittelkow MR, Plowman GD, Shoyab M, Adelman JP, Shipley GD. 1991. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol 11: 2547-2557.
18. Coussens LM, Fingleton B, Matrisian LM. 2002. Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295: 2387-2392.
19. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M. 2004. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol 271: 263-271.
20. DasGupta S, Murumkar PR, Giridhar R, Yadav MR. 2009. Current perspective of TACE inhibitors: A review. Bioorg Med Chem 17: 444-459.
21. Davis CG. 1990. The many faces of epidermal growth factor repeats. New Biol 2: 410-419.
22. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD. 1994. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266: 816-819.
23. Delwig A, RandMD. 2008. Kuz andTACEcan activateNotch independent of ligand. Cell Mol Life Sci 65: 2232-2243.
24. Dempsey PJ, Meise KS, Yoshitake Y, Nishikawa K, Coffey RJ. 1997. Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor. J Cell Biol 138: 747-758.
25. Diaz-Rodriguez E, Montero JC, Esparis-Ogando A, Yuste L, Pandiella A. 2002. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor a-converting enzyme at threonine 735: A potential role in regulated shedding. Mol Biol Cell 13: 2031-2044.
26. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP. 1989. Autocrine interaction between TGF-a and the EGF-receptor: Quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831-838.
27. Doedens JR, Mahimkar RM, Black RA. 2003. TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. Biochem BiophysResCommun308: 331-338.
28. Dong J, Opresko LK, Dempsey PJ, LauffenburgerDA, Coffey RJ, Wiley HS. 1999. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. ProcNatl Acad Sci 96: 6235-6240.
29. Edwards DR, Handsley MM, Pennington CJ. 2008. The ADAM metalloproteinases. Mol Aspects Med 29: 258-289.
30. Falls DL. 2003. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284: 14-30.
31. Fambrough D, Pan D, Rubin GM, Goodman CS. 1996. The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila. Proc Natl Acad Sci 93: 13233-13238.
32. Fan H, Turck CW, Derynck R. 2003. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-a converting enzyme and of an alternatively translated polypeptide. J Biol Chem 278: 18617-18627.
33. Foltenyi K, Greenspan RJ, Newport JW. 2007. Activation of EGFR and ERK by rhomboid signaling regulates the consolidation and maintenance of sleep in Drosophila. Nat Neurosci 10: 1160-1167.
34. Freeman M. 1994. The Spitz gene is required for photoreceptor determination in the Drosophila eye where it interacts with the EGF receptor. Mech Dev 48: 25-33.
35. Freeman M. 1998. Complexity of EGF receptor signalling revealed in Drosophila. Curr Opin Genet Dev 8: 407-411.
36. Freeman M. 2009. Rhomboids: 7 years of a new protease family. Semin Cell Dev Biol 20: 231-239.
37. Georgakopoulos A, Litterst C, Ghersi E, Baki L, Xu C, Serban G, Robakis NK. 2006. Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J 25: 1242-1252.
38. Gonzales PE, Galli JD, Milla ME. 2008. Identification of key sequence determinants for the inhibitory function of the prodomain of TACE. Biochemistry 47: 9911-9919.
39. Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A. 2001. Cell communication networks: Epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20: 1594-1600.
40. Guinea-Viniegra J, Zenz R, Scheuch H, Hnisz D, Holcmann M, Bakiri L, Schonthaler HB, Sibilia M, Wagner EF. 2009. TNFa shedding and epidermal inflammation are controlled by Jun proteins. Genes Dev 23: 2663-2674.
41. Gullick WJ. 1991. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47: 87-98.
42. Harris RC, Chung E, Coffey RJ. 2003. EGF receptor ligands. Exp Cell Res 284: 2-13.
43. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena Illert A, von Figura K, et al. 2002. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for a-secretase activity in fibroblasts. Hum Mol Genet 11: 2615-2624.
44. Hattori M, Osterfield M, Flanagan JG. 2000. Regulated cleavage of a contact-mediated axon repellent. Science 289: 1360-1365.
45. Hemler ME. 2005. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6: 801-811.
46. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251: 936-939.
47. Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E. 1995. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol 128: 929-938.
48. Horiuchi K, Le Gall S, Schulte M, Yamaguchi T, Reiss K, Murphy G, Toyama Y, Hartmann D, Saftig P, Blobel CP. 2007a. Substrate selectivity of epidermal growth factorreceptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 18: 176-188.
49. Horiuchi K, Miyamoto T, Takaishi H, Hakozaki A, Kosaki N, Miyauchi Y, Furukawa M, Takito J, Kaneko H, Matsuzaki K, et al. 2007b. Cell surface colony-stimulating factor 1 can be cleaved by TNF-a converting enzyme or endocytosed in a clathrin-dependent manner. J Immunol 179: 6715-6724.
50. Horiuchi K, Morioka H, Takaishi H, Akiyama H, Blobel CP, Toyama Y. 2009. Ectodomain shedding of FLT3 ligand is mediated by TNF-a converting enzyme. J Immunol 182: 7408-7414.
51. Huang EJ, Nocka KH, Buck J, Besmer P. 1992. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 3: 349-362.
52. Imhof I, Gasper WJ, Derynck R. 2008. Association of tetraspanin CD9 with transmembrane TGF-a confers alterations in cell-surface presentation of TGF-a and cytoskeletal organization. J Cell Sci 121: 2265-2274.
53. Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K, Adachi S, Kitakaze M, Hashimoto K, Raab G, et al. 2003. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci 100: 3221-3226.
54. Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, et al. 1998. A metalloprotease-disintegrin, MDC9/meltrin-g/ ADAM9 and PKCd are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J 17: 7260-7272.
55. Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB. 2005. Adam meets Eph: An ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123: 291-304.
56. Jansens A, van Duijn E, Braakman I. 2002. Coordinated nonvectorial folding in a newly synthesized multidomain protein. Science 298: 2401-2403.
57. Kawaguchi N, Horiuchi K, Becherer JD, Toyama Y, Besmer P, Blobel CP. 2007. DifferentADAMs have distinct influences on Kit ligand processing: Phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19. J Cell Sci 120: 943-952.
58. Lappano R, Maggiolini M. 2011. G protein-coupled receptors: Novel targets for drug discovery in cancer. Nat Rev Drug Discov 10: 47-60.
59. Lee JR, Urban S, Garvey CF, Freeman M. 2001. Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila. Cell 107: 161-171.
60. Le Gall SM, Meneton P, Mauduit P, Dreux C. 2004. The sequential cleavage of membrane anchored pro-EGF requires a membrane serine protease other than kallikrein in rat kidney. Regul Pept 122: 119-129.
61. Le Gall SM, Bobe P, Reiss K, Horiuchi K, Niu XD, LundellD, Gibb DR, Conrad D, Saftig P, Blobel CP. 2009. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor a, L-selectin, and tumor necrosis factor a. Mol Biol Cell 20: 1785-1794.
62. Le Gall SM, Maretzky T, Issuree PD, Niu XD, Reiss K, Saftig P, Khokha R, Lundell D, Blobel CP. 2010. ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J Cell Sci 123: 3913-3922.
63. Lemberg MK, Menendez J, Misik A, Garcia M, Koth CM, Freeman M. 2005. Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. EMBO J 24: 464-472.
64. Lemjabbar H, Basbaum C. 2002. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med 8: 41-46.
65. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
66. Leonard JD, Lin F, Milla ME. 2005. Chaperone-like properties of the prodomain of TNFa-converting enzyme (TACE) and the functional role of its cysteine switch. Biochem J 387: 797-805.
67. Lieberman RL, Wolfe MS. 2007. From rhomboid function to structure and back again. Proc Natl Acad Sci 104: 8199-8200.
68. Lohi O, Urban S, Freeman M. 2004. Diverse substrate recognition mechanisms for rhomboids; thrombomodulin is cleaved by Mammalian rhomboids. Curr Biol 14: 236-241.
69. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC. 1993. TGF-a deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73: 263-278.
70. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR. 1993. Mice with a null mutation of the TGFa gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73: 249-261.
71. Massague J, Pandiella A. 1993. Membrane-anchored growth factors. Annu Rev Biochem 62: 515-541.
72. McIlwain DR, Lang PA, Maretzky T, Hamada K, KazuhitoO, KumarManey S, Berger T, Murthy A, Duncan G, Xu HC, et al. 2012. iRhom2 regulates innate immunity via TACE/ ADAM17. Science 335: 229-232.
73. Merlos-Suarez A, Ruiz-Paz S, Baselga J, Arribas J. 2001. Metalloprotease-dependent protransforming growth factor-a ectodomain shedding in the absence of tumor necrosis factor-a-converting enzyme. J Biol Chem 276: 48510-48517.
74. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, et al. 2004. Abnormal TNF activity in Timp32/2 mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36: 969-977.
75. Murayama Y, Shinomura Y, Oritani K, Miyagawa J, Yoshida H, Nishida M, Katsube F, Shiraga M, Miyazaki T, Nakamoto T, et al. 2008. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol 216: 135-143.
76. Murphy G. 2008. The ADAMs: Signalling scissors in the tumour microenvironment. Nat Rev Cancer 8: 929-941.
77. Murphy G. 2009. Regulation of the proteolytic disintegrin metalloproteinases, the "Sheddases. " Semin Cell Dev Biol 20: 138-145.
78. Murphy G. 2011. Tissue inhibitors of metalloproteinases. Genome Biol 12: 233.
79. Murthy A, Defamie V, Smookler DS, Di Grappa MA, Horiuchi K, Federici M, Sibilia M, Blobel CP, Khokha R. 2010. Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest 120: 2731-2744.
80. Nakagawa T, Guichard A, Castro CP, Xiao Y, Rizen M, Zhang HZ, Hu D, Bang A, Helms J, Bier E, et al. 2005. Characterization of a human rhomboid homolog, p100hRho/ RHBDF1, which interacts with TGF-a family ligands. Dev Dyn 233: 1315-1331.
81. Naoe T, Kiyoi H. 2004. Normal and oncogenic FLT3. Cell Mol Life Sci 61: 2932-2938.
82. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. 2003. Anti-TNF-a therapies: The next generation. Nat Rev Drug Discov 2: 736-746.
83. Pandiella A, BosenbergMW, Huang EJ, Besmer P, Massague J. 1992. Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. J Biol Chem 267: 24028-24033.
84. Pascall JC, Brown KD. 2004. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem Biophys Res Commun 317: 244-252.
85. Peiretti F, Canault M, Deprez-Beauclair P, Berthet V, Bonardo B, Juhan-Vague I, Nalbone G. 2003a. Intracellular maturation and transport of tumor necrosis factor a converting enzyme. Exp Cell Res 285: 278-285.
86. Peiretti F, Deprez-Beauclair P, Bonardo B, Aubert H, Juhan-Vague I, Nalbone G. 2003b. Identification of SAP97 as an intracellular binding partner of TACE. J Cell Sci 116: 1949-1957.
87. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, et al. 1998. An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284.
88. Piepkorn M, Pittelkow MR, Cook PW. 1998. Autocrine regulation of keratinocytes: The emerging role of heparinbinding, epidermal growth factor-related growth factors. J Invest Dermatol 111: 715-721.
89. Pitulescu ME, Adams RH. 2010. Eph/ephrin molecules-A hub for signaling and endocytosis. Genes Dev 24: 2480-2492.
90. Puente XS, Lopez-Otin C. 2004. A genomic analysis of rat proteases and protease inhibitors. Genome Res 14: 609-622.
91. Rovida E, Paccagnini A, DelRossoM, PeschonJ, Dello Sbarba P. 2001. TNF-a-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol 166: 1583-1589.
92. Ruohola-Baker H, Grell E, Chou TB, Baker D, Jan LY, Jan YN. 1993. Spatially localized rhomboid is required for establishment of the dorsal-ventral axis in Drosophila oogenesis. Cell 73: 953-965.
93. Saftig P, Reiss K. 2011. The "A disintegrin and metalloproteases" ADAM10 and ADAM17: Novel drug targets with therapeutic potential? Eur J Cell Biol 90: 527-535.
94. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, HartmannD, Saftig P, Blobel CP. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164: 769-779.
95. Salomon DS, Brandt R, Ciardiello F, Normanno N. 1995. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19: 183-232.
96. SandersonMP, Erickson SN, Gough PJ, Garton KJ, Wille PT, Raines EW, Dunbar AJ, Dempsey PJ. 2005. ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx. J Biol Chem 280: 1826-1837.
97. Sastry SK, Elferink LA. 2011. Checks and balances: Interplay of RTKs and PTPs in cancer progression. Biochem Pharmacol 82: 435-440.
98. Schafer B, Marg B, Gschwind A, Ullrich A. 2004. Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J Biol Chem 279: 47929-47938.
99. Schlesinger A, Kiger A, Perrimon N, Shilo BZ. 2004. Small wing PLCg is required for ER retention of cleaved Spitz during eye development in Drosophila. Dev Cell 7: 535-545.
100. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
101. Schlondorff J, Becherer JD, Blobel CP. 2000. Intracellular maturation and localization of the tumour necrosis factor a convertase (TACE). Biochem J 347: 131-138.
102. Schneider MR, Wolf E. 2009. The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218: 460-466.
103. Seals DF, Courtneidge SA. 2003. The ADAMs family of metalloproteases: Multidomain proteins with multiple functions. Genes Dev 17: 7-30.
104. Shilo BZ. 2003. Signaling by the Drosophila epidermal growth factor receptor pathway during development. Exp Cell Res 284: 140-149.
105. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. 2007. The epidermal growth factor receptor: From development to tumorigenesis. Differentiation 75: 770-787.
106. Siggs OM, Xiao N, Wang Y, Shi H, Tomisato W, Li X, Xia Y, Beutler B. 2012. iRhom2 is required for the secretion of mouse TNF a. Blood 119: 5769-5771.
107. Singh AB, Harris RC. 2005. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 17: 1183-1193.
108. Smith KM, Gaultier A, Cousin H, Alfandari D, White JM, DeSimone DW. 2002. The cysteine-rich domain regulates ADAM protease function in vivo. J Cell Biol 159: 893-902.
109. Smith MH, Ploegh HL, Weissman JS. 2011. Road to ruin: Targeting proteins for degradation in the endoplasmic reticulum. Science 334: 1086-1090.
110. Soond SM, Everson B, Riches DW, Murphy G. 2005. ERKmediated phosphorylation of Thr735 in TNFa-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 118: 2371-2380.
111. Sporn MB, Roberts AB. 1985. Autocrine growth factors and cancer. Nature 313: 745-747.
112. Strisovsky K, Sharpe HJ, Freeman M. 2009. Sequencespecific intramembrane proteolysis: Identification of a recognition motif in rhomboid substrates. Mol Cell 36: 1048-1059.
113. Sturtevant MA, Roark M, Bier E. 1993. The Drosophila rhomboid gene mediates the localized formation of wing veins and interacts genetically with components of the EGF-R signaling pathway. Genes Dev 7: 961-973.
114. SunnarborgSW, Hinkle CL, StevensonM, RussellWE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, et al. 2002. Tumor necrosis factor-a converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277: 12838-12845.
115. Tanaka M, NanbaD, Mori S, Shiba F, Ishiguro H, Yoshino K, Matsuura N, Higashiyama S. 2004. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands. J Biol Chem 279: 41950-41959.
116. Tsruya R, Wojtalla A, Carmon S, Yogev S, Reich A, Bibi E, Merdes G, Schejter E, Shilo BZ. 2007. Rhomboid cleaves Star to regulate the levels of secreted Spitz. EMBO J 26: 1211-1220.
117. Ullrich A, Schlessinger J. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212.
118. Urban S, DickeySW. 2011. The rhomboid protease family: A decade of progress on function and mechanism. Genome Biol 12: 231.
119. Urban S, Freeman M. 2003. Substrate specificity of rhomboid intramembrane proteases is governed by helixbreaking residues in the substrate transmembrane domain. Mol Cell 11: 1425-1434.
120. Urban S, Lee JR, Freeman M. 2001. Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases. Cell 107: 173-182.
121. Urban S, Lee JR, Freeman M. 2002. A family of rhomboid intramembrane proteases activates all Drosophila membrane-tethered EGF ligands. EMBO J 21: 4277-4286.
122. Wang Y, Zhang Y, Ha Y. 2006. Crystal structure of a rhomboid family intramembrane protease. Nature 444: 179-180.
123. Ward CL, Kopito RR. 1994. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J Biol Chem 269: 25710-25718.
124. Wasserman JD, Urban S, Freeman M. 2000. A family of rhomboid-like genes: Drosophila rhomboid-1 and roughoid/rhomboid-3 cooperate to activate EGF receptor signaling. Genes Dev 14: 1651-1663.
125. White JM. 2003. ADAMs:Modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15: 598-606.
126. Wisniewska M, Goettig P, Maskos K, Belouski E, Winters D, Hecht R, Black R, BodeW. 2008. Structural determinants of the ADAM inhibition by TIMP-3: Crystal structure of the TACE-N-TIMP-3 complex. J Mol Biol 381: 1307-1319.
127. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J. 2004. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022-7029.
128. Xu P, Derynck R. 2010. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell 37: 551-566.
129. Xu D, Sharma C, Hemler ME. 2009. Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 23: 3674-3681.
130. Yamazaki S, Iwamoto R, Saeki K, Asakura M, Takashima S, Yamazaki A, Kimura R, Mizushima H, Moribe H, Higashiyama S, et al. 2003. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 163: 469-475.
131. Yan Z, Zou H, Tian F, Grandis JR, Mixson AJ, Lu PY, Li LY. 2008. Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth. Mol Cancer Ther 7: 1355-1364.
132. Yanez-Mo M, Gutierrez-LopezMD, Cabanas C. 2011. Functional interplay between tetraspanins and proteases. Cell Mol Life Sci 68: 3323-3335.
133. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
134. Yogev S, Schejter ED, Shilo BZ. 2008. Drosophila EGFR signalling is modulated by differential compartmentalization of rhomboid intramembrane proteases. EMBO J 27: 1219-1230.
135. Zettl M, Adrain C, Strisovsky K, Lastun V, Freeman M. 2011. Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling. Cell 145: 79-91.
136. Zheng Y, Schlondorff J, Blobel CP. 2002. Evidence for regulation of the tumor necrosis factor a-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J Biol Chem 277: 42463-42470.